批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
| 审批日期 | 提交号 | 审批结论 | 提交分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2009/11/05 |
ORIG-1(原始申请) |
Approval |
Type 1 - New Molecular Entity |
STANDARD
;Orphan
|
|
|
>>>补充申请<<<
| 审批日期 | 提交号 | 审批结论 | 补充类别或审批类型 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2021/07/30 |
SUPPL-17(补充) |
Approval |
Efficacy-Labeling Change With Clinical Data |
STANDARD
;Orphan
|
|
|
| 2021/03/24 |
SUPPL-16(补充) |
Approval |
Labeling-Package Insert |
STANDARD
;Orphan
|
|
|
| 2018/11/27 |
SUPPL-15(补充) |
Approval |
Labeling-Package Insert,Labeling-Patient Package Insert |
STANDARD
;Orphan
|
|
|
| 2016/07/27 |
SUPPL-14(补充) |
Approval |
Labeling-Container/Carton Labels |
STANDARD
;Orphan
|
|
|
| 2014/10/15 |
SUPPL-13(补充) |
Approval |
Efficacy-Labeling Change With Clinical Data |
STANDARD
|
|
|
| 2013/09/13 |
SUPPL-12(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2013/06/13 |
SUPPL-11(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2011/09/30 |
SUPPL-6(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2011/06/16 |
SUPPL-4(补充) |
Approval |
Efficacy-New Indication |
PRIORITY
|
|
|
| 2011/04/12 |
SUPPL-1(补充) |
Approval |
Labeling-Container/Carton Labels,Labeling-Package Insert |
UNKNOWN
;Orphan
|
|
|
与本品治疗等效的药品
>>>活性成分:ROMIDEPSIN; 剂型/给药途径:POWDER;INTRAVENOUS; 规格:10MG/VIAL; 治疗等效代码:AP<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 022393 |
001 |
NDA |
ISTODAX |
ROMIDEPSIN |
POWDER;INTRAVENOUS |
10MG/VIAL |
Prescription |
Yes |
Yes |
AP |
2009/11/05
|
BRISTOL-MYERS |
| 206254 |
001 |
ANDA |
ROMIDEPSIN |
ROMIDEPSIN |
POWDER;INTRAVENOUS |
10MG/VIAL |
Prescription |
No |
No |
AP |
2021/10/12
|
FRESENIUS KABI USA |